Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer’s disease

被引：1

作者：

Andrew K. Evans ^{[1
]}

Heui Hye Park ^{[1
]}

Claire E. Woods ^{[1
]}

Rachel K. Lam ^{[1
]}

Daniel Ryskamp Rijsketic ^{[1
]}

Christine Xu ^{[2
]}

Emily K. Chu ^{[1
]}

Peter Ciari ^{[1
]}

Sarah Blumenfeld ^{[1
]}

Laura M. Vidano ^{[1
]}

Nay Lui Saw ^{[1
]}

Boris D. Heifets ^{[1
]}

Mehrdad Shamloo ^{[2
]}

机构：

[1] Stanford University School of Medicine,Department of Neurosurgery

[2] Stanford University School of Medicine,Department of Anesthesiology, Perioperative, and Pain Medicine

[3] Stanford University School of Medicine,Department of Psychiatry and Behavioral Sciences

来源：

Journal of Neuroinflammation | / 21卷 / 1期

关键词：

Alzheimer’s Disease; Norepinephrine; Locus coeruleus; Beta-adrenergic receptor; Beta-blocker; Neuroinflammation; iDISCO+; Amyloid beta; Microglia;

D O I：

10.1186/s12974-024-03306-1

中图分类号：

学科分类号：

摘要：

Norepinephrine (NE) modulates cognitive function, arousal, attention, and responses to novelty and stress, and it also regulates neuroinflammation. We previously demonstrated behavioral and immunomodulatory effects of beta-adrenergic pharmacology in mouse models of Alzheimer’s disease (AD). The current studies were designed to block noradrenergic signaling in 5XFAD mice through (1) chemogenetic inhibition of the locus coeruleus (LC), (2) pharmacologic blocking of β-adrenergic receptors, and (3) conditional deletion of β1- or β2-adrenergic receptors (adrb1 or adrb2) in microglia.

引用

共 50 条

[41] The pathophysiology of Alzheimer's disease
Roberts, GW
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P380 - P380
[42] Pathophysiology of Alzheimer's disease
Sanchez Mario, Alvarez
Ivonne, Pedroso
Amado, de la Fe
Sanchez Arnoldo, Padron
Sanchez Marilet, Alvarez
Lazaro, Alvarez
REVISTA MEXICANA DE NEUROCIENCIA, 2008, 9 (03): : 196 - 201
[43] Pathophysiology of Alzheimer's Disease
Yarns, Brandon C.
Holiday, Kelsey A.
Carlson, David M.
Cosgrove, Coleman K.
Melrose, Rebecca J.
PSYCHIATRIC CLINICS OF NORTH AMERICA, 2022, 45 (04) : 663 - 676
[44] Pathophysiology of Alzheimer's disease
Imbimbo, BP
Lombard, J
Pomara, N
NEUROIMAGING CLINICS OF NORTH AMERICA, 2005, 15 (04) : 727 - +
[45] Probiotics ameliorate intestinal pathophysiology in a mouse model of Alzheimer ?s disease
Kaur, Harpreet
Nagamoto-Combs, Kumi
Golovko, Svetlana
Golovko, Mikhail Y.
Klug, Marilyn G.
Combs, Colin Kelly
NEUROBIOLOGY OF AGING, 2020, 92 : 114 - 134
[46] Circular RNA aptamers targeting neuroinflammation ameliorate Alzheimer disease phenotypes in mouse models
Feng, Xin
Jiang, Bo-Wen
Zhai, Si-Nan
Liu, Chu-Xiao
Wu, Hao
Zhu, Bang-Qi
Wei, Meng-Yuan
Wei, Jia
Yang, Li
Chen, Ling-Ling
NATURE BIOTECHNOLOGY, 2025,
[47] Impact of Neuroinflammation on Hippocampal Neurogenesis: Relevance to Aging and Alzheimer's Disease
Valero, Jorge
Bernardino, Liliana
Cardoso, Filipa Lourenco
Silva, Ana Paula
Fontes-Ribeiro, Carlos
Ambrosio, Antonio Francisco
Malva, Joao Oliveira
JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 : S161 - S168
[48] Pathophysiology in the suprachiasmatic nucleus in mouse models of Huntington's disease
Kuljis, Dika
Kudo, Takashi
Tahara, Yu
Ghiani, Cristina A.
Colwell, Christopher S.
JOURNAL OF NEUROSCIENCE RESEARCH, 2018, 96 (12) : 1862 - 1875
[49] Neuroinflammation in Alzheimer's disease and prion disease
Eikelenboom, P
Bate, C
Van Gool, WA
Hoozemans, JJM
Rozemuller, JM
Veerhuis, R
Williams, A
GLIA, 2002, 40 (02) : 232 - 239
[50] An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease
Ghosh, Anamitra
Comerota, Michele M.
Wan, Debin
Chen, Fading
Propson, Nicholas E.
Hwang, Sung Hee
Hammock, Bruce D.
Zheng, Hui
SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (573)

← 1 2 3 4 5 →